Exelixis
EXEL
#1657
Rank
NZ$22.70 B
Marketcap
NZ$90.33
Share price
-1.01%
Change (1 day)
33.06%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company